Skip to main content

Expert Insights

Pharmacy Learning Network
Soumya Vishwanath, PharmD, University of Massachusetts Medical School, discusses digital therapeutics, which she says is the next wave of patient care, and highlights why it’s essential to assess how these products may play a role in clinical therapy and evaluate their impact on key stakeholders.
Pharmacy Learning Network
In this week’s issue of Talking Therapeutics, Dr Jennings explores a new drug approval and what it means for patients with chronic kidney disease.
First Report Managed Care
Han-Zhu Qian, MD, PhD, MPH, explains the importance of screening cognitive functions and identifying the domains of cognitive impairment by age group among people living with HIV.
Pharmacy Learning Network
“Goal-directed use of antihypertensives and statin drugs appear to be effective strategies to reduce atrial fibrillation incidence, morbidity, and mortality,” says Mark Munger, PharmD.
First Report Managed Care
Michael Drummond PhD, Professor of Health Economics, University of York, UK, and Allen Lising, Managing Director of FormularyDecisions, a part of AmerisourceBergen, offer insight from their recent study which assessed the current use of cost-effectiveness analyses in decision-making for the…
First Report Managed Care
Jenn Dellwo, Icario, introduces an innovative, closed-loop survey approach focused on capturing member experiences early to proactively impact satisfaction ahead of the CAHPS survey.
First Report Managed Care
Diane Smith, PhD, associate director of reimbursement…
Annals of Long-Term Care
Michael Gordon, MD, MSc, FRCPC, discusses his early experiences with electroconvulsive therapy (ECT)—treatment often used for patients with severe depression—and highlights how the balance of antidepressant treatment and ECT has shifted over time to benefit severely depressed older patients.
Annals of Long-Term Care
Brittany H Cone, Esq, and Jordan S Johnson, Esq, attorneys at Hall Booth Smith, PC, talk through the Medicaid program, current practical issues that the long-term care industry is facing, and provide a few possible approaches and solutions to these issues.
Pharmacy Learning Network
In this week’s issue of Talking Therapeutics, Dr Jennings explores the science and promise of a recently approved novel medication for patients with HFrEF.
Back to Top